Stevanato Group to Present at Upcoming Investor Conferences
Stevanato Group (NYSE: STVN), a global leader in drug containment and delivery solutions, has announced its participation in three major investor conferences. The company will join the UBS Global Healthcare Conference in California on November 12, 2024, the Jefferies London Healthcare Conference on November 19, 2024, and the Citi 2024 Global Healthcare Conference in Miami on December 3, 2024.
Live webcasts of all presentations will be available on the company's website under the Investors section, with replays accessible for approximately 90 days following each event.
Stevanato Group (NYSE: STVN), leader globale nelle soluzioni per il contenimento e la somministrazione di farmaci, ha annunciato la sua partecipazione a tre importanti conferenze per investitori. L'azienda prenderà parte alla UBS Global Healthcare Conference in California il 12 novembre 2024, alla Jefferies London Healthcare Conference il 19 novembre 2024 e alla Citi 2024 Global Healthcare Conference a Miami il 3 dicembre 2024.
I webcast in diretta di tutte le presentazioni saranno disponibili sul sito web dell'azienda nella sezione Investitori, con possibilità di rivedere le registrazioni per circa 90 giorni dopo ogni evento.
Stevanato Group (NYSE: STVN), líder global en soluciones de contención y entrega de medicamentos, ha anunciado su participación en tres conferencias importantes para inversores. La compañía asistirá a la UBS Global Healthcare Conference en California el 12 de noviembre de 2024, a la Jefferies London Healthcare Conference el 19 de noviembre de 2024 y a la Citi 2024 Global Healthcare Conference en Miami el 3 de diciembre de 2024.
Las transmisiones en vivo de todas las presentaciones estarán disponibles en el sitio web de la empresa en la sección de Inversores, y las repeticiones se podrán acceder durante aproximadamente 90 días después de cada evento.
Stevanato Group (NYSE: STVN)은 의약품 보관 및 전달 솔루션의 글로벌 리더로서 세 개의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사는 2024년 11월 12일 캘리포니아에서 열리는 UBS Global Healthcare Conference, 2024년 11월 19일 런던에서 열리는 Jefferies London Healthcare Conference, 그리고 2024년 12월 3일 마이애미에서 열리는 Citi 2024 Global Healthcare Conference에 참석합니다.
모든 발표의 라이브 웹캐스트는 회사 웹사이트의 투자자 섹션에서 이용 가능하며, 각 이벤트 후 약 90일 동안 다시 볼 수 있습니다.
Stevanato Group (NYSE: STVN), leader mondial en solutions de confinement et de livraison de médicaments, a annoncé sa participation à trois grandes conférences pour investisseurs. L'entreprise participera à la UBS Global Healthcare Conference en Californie le 12 novembre 2024, à la Jefferies London Healthcare Conference le 19 novembre 2024 et à la Citi 2024 Global Healthcare Conference à Miami le 3 décembre 2024.
Les webémissions en direct de toutes les présentations seront disponibles sur le site web de l'entreprise dans la section Investisseurs, avec des rediffusions accessibles pendant environ 90 jours après chaque événement.
Stevanato Group (NYSE: STVN), ein globaler Marktführer im Bereich der Arzneimittelcontainment und -abgabe Lösungen, hat seine Teilnahme an drei wichtigen Investorenkonferenzen bekannt gegeben. Das Unternehmen wird an der UBS Global Healthcare Conference in Kalifornien am 12. November 2024, an der Jefferies London Healthcare Conference am 19. November 2024 sowie an der Citi 2024 Global Healthcare Conference in Miami am 3. Dezember 2024 teilnehmen.
Live-Webcasts aller Präsentationen sind auf der Unternehmenswebsite im Bereich Investoren verfügbar, mit Wiederholungen, die ungefähr 90 Tage nach jeder Veranstaltung zugänglich sind.
- None.
- None.
PIOMBINO DESE,
The Company will participate in a fireside chat at the UBS Global Healthcare Conference in
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. To learn more, visit: www.stevanatogroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111945147/en/
Media
Stevanato Group
media@stevanatogroup.com
Investor Relations
Lisa Miles
lisa.miles@stevanatogroup.com
Source: Stevanato Group
FAQ
When is Stevanato Group (STVN) presenting at the UBS Global Healthcare Conference 2024?
What time is Stevanato Group's (STVN) presentation at the Jefferies London Healthcare Conference 2024?
How long will the webcasts of Stevanato Group's (STVN) investor conference presentations be available?